vimarsana.com

Latest Breaking News On - Xlife sciences - Page 4 : vimarsana.com

Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23 3 million

Xlife Sciences AG / Key word(s): Disposal/Investment Successful exit of portfolio company and major invest in AI and digital health in .

Oliverr baumannXlife sciencesZurich xlife sciencesXlife science

Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23 3 million - adhoc - Börsennachrichten

Xlife Sciences AG Key word DisposalInvestment Successful exit of portfolio company and major invest in AI and digital health in early cancer detection valued at CHF 233 million 18Oct2023 0700 CETCEST

Oliverr baumannXlife sciencesZurich xlife sciencesXlife science

4D Lifetec Secures CHF 23 3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer

4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer DetectionZURICH / CHAM, Switzerland, October 18, 2023 / B3C newswire / In a significant financial milestone, Xlife Sciences AG invests CHF 23.3 million in 4D Lifet.

Arne christian faisstOliverr baumannGiancarlo rizzoliXlife sciencesXlife sciences opening new horizons in usingDigital health in early cancer detectionLifetec securesInvestment dealXlife sciences opening new horizonsDigital healthEarly cancer

While private companies own 30% of Xlife Sciences AG (VTX:XLS), retail investors are its largest shareholders with 47% ownership

Key Insights The considerable ownership by retail investors in Xlife Sciences indicates that they collectively have a.

Institutional ownership tell us about xlife sciencesCompany ownershipVartex internationalXlife sciencesAkira holdingGilbert schPrivate companiesXlife sciences agOwnership structureRetail investorsPrivate companies

Xlife Sciences with significant progress in H1 2023 - adhoc - Börsennachrichten

Xlife Sciences AG Key word Half Year Results Xlife Sciences with significant progress in H1 2023 21Sep2023 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely re

United statesAbu dhabiAbuz abyUnited arab emiratesOliverr baumannAxenoll life sciencesDepartment of healthDrug administrationDepartment of neurology universitXlife sciencesEuropean patent officeCantonal hospital aarauProstate carcinomaLife sciencesKey figuresXlife science

vimarsana © 2020. All Rights Reserved.